1-8 of 8
Sally W Wade
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Short-Term Costs Associated with Outpatient Use of Axicabtagene Ciloleucel in Second-Line Relapsed/Refractory Large B-Cell Lymphoma Based on Zuma-24 Clinical Trial

Olalekan O. Oluwole, Sally W. Wade, Nathaniel J Smith, Tomas Spousta, Jenny J. Kim, Yan Zheng, Timothy Best, Markqayne Ray, Lori A. Leslie
Journal: Blood
Blood (2024) 144 (Supplement 1): 7607.
https://doi.org/10.1182/blood-2024-206879
Published: 2024
Journal Articles

A United States (US) Cost-Effectiveness Analysis of Axicabtagene Ciloleucel Compared to Odronextamab in Third Line or Later (3L+) Diffuse Large B-Cell Lymphoma

Frederick Locke, Bradley Kievit, Sally W. Wade, Rob Blisset, Markqayne Ray, Madhu Palivela, Timothy Best, Olalekan O. Oluwole
Journal: Blood
Blood (2024) 144 (Supplement 1): 7592.
https://doi.org/10.1182/blood-2024-199622
Published: 2024
Journal Articles

Matching-Adjusted Indirect Comparison (MAIC) of Brexucabtagene Autoleucel (Brexu-cel) and Pirtobrutinib in Patients with Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL) Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor (cBTKi)

Jenny M.H. Chen, Ina Zhang, James J. Wu, Sally W. Wade, Ana Nunes, Weimin Peng, Julia T. Snider, Dylan Maciel, Keith Chan, Sam Keeping, Bijal D. Shah
Journal: Blood
Blood (2023) 142 (Supplement 1): 5136.
https://doi.org/10.1182/blood-2023-177741
Published: 2023
Journal Articles

Chimeric Antigen Receptor T-Cell Therapy Setting of Care: A Retrospective Cohort Analysis of MCL and FL Patients in the US

Roxanna Seyedin, Ken Hasegawa, Krithika Rajagopalan, Sally W Wade
Journal: Blood
Blood (2022) 140 (Supplement 1): 3642–3643.
https://doi.org/10.1182/blood-2022-157473
Published: 2022
Journal Articles

Hospital Costs and Healthcare Resource Utilization (HRU) for Chimeric Antigen (CAR) T-Cell Therapy and Stem Cell Transplant (SCT) in Patients with Large B-Cell Lymphoma (LBCL) in the United States (US)

Chendi Cui, Chaoling Feng, Ning Rosenthal, Sally W Wade, Laura Curry, Christine Fu, Gunjan L. Shah
Journal: Blood
Blood (2022) 140 (Supplement 1): 2161–2162.
https://doi.org/10.1182/blood-2022-157309
Published: 2022
Journal Articles

Network Meta-Analysis (NMA) of Chimeric Antigen Receptor (CAR) T-Cell Therapy for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) after 2 Prior Treatments Using Published Comparative Studies

Frederick L. Locke, Sattva S. Neelapu, Markqayne D. Ray, Eve H Limbrick-Oldfield, Sally W Wade, Steve Kanters, Anik R. Patel, Olalekan O. Oluwole
Journal: Blood
Blood (2022) 140 (Supplement 1): 7516–7518.
https://doi.org/10.1182/blood-2022-169812
Published: 2022
Journal Articles

Chimeric Antigen Receptor T-Cell Therapy Treatment Patterns: A Retrospective Cohort Analysis of Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients in the US

Roxanna Seyedin, Julia Thornton Snider, Krithika Rajagopalan, Sally W Wade, Usama Gergis
Journal: Blood
Blood (2021) 138 (Supplement 1): 1424.
https://doi.org/10.1182/blood-2021-148067
Published: 2021
Journal Articles

A Comparison of Clinical Outcomes from Updated Zuma-5 (Axicabtagene Ciloleucel) and the International Scholar-5 External Control Cohort in Relapsed/Refractory Follicular Lymphoma (R/R FL)

M. Lia Palomba, Paola Ghione, Anik R. Patel, Kevin Deighton, Caron Jacobson, Myrna Nahas, A Scott Jung, Anthony J Hatswell, Steve Kanters, Eve Limbrick-Oldfield, Sally W Wade, Julia Thornton Snider, Sattva S. Neelapu, Maria Teresa Riberio, John Gribben, John Radford, Sabela Bobillo, Herve Ghesquieres
Journal: Blood
Blood (2021) 138 (Supplement 1): 3543.
https://doi.org/10.1182/blood-2021-147608
Published: 2021